Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Braskem says Q2 resin sales volumes fall in Brazil as imports rise

Braskem says Q2 resin sales volumes fall in Brazil as imports rise

ReutersReuters2026/07/31 10:07
  • Braskem released a 2Q26 production and sales update, citing higher international resin and chemical prices versus 1Q26 amid Middle East-driven feedstock volatility.
  • Brazil/South America: cracker utilization rate up 1 pp vs 1Q26, down 4 pp vs 2Q25; domestic resin sales volume down 2% q/q.
  • Export resin volume fell 4% q/q, down 23% y/y; domestic main chemicals sales volume dropped 4% q/q, down 5% y/y.
  • US/Europe: PP plant utilization down 3 pp q/q due to maintenance; PP sales volume flat q/q, down 1% y/y.
  • Mexico: PE plant utilization down 12 pp q/q; PE sales volume down 11% q/q, down 20% y/y.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Braskem SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001292814-26-003992), on July 31, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application

Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.

智通财经2026/09/05 01:16
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application